tiprankstipranks
Trending News
More News >
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Revenue

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Revenue

BrightPath Biotherapeutics Co.Ltd. had a revenue of 23.00K in the quarter ending Dec 31, 2023, with -17.86%. This bring the company's revenue in the last twelve months to 118.00K, Increased -97.71%. In the fiscal year ending Mar 31, 2025, BrightPath Biotherapeutics Co.Ltd. had annual revenue of 1.13M with 1473.61% growth.
Revenue (ttm)
118.00K
Revenue Growth
1221.43%
P/S Ratio
8826.27
Revenue/Employee
¥26,976
Employees
42
Market Cap
¥10.00B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
1.13M1.06M+1,473.61%
Mar 31, 2024
72.00K-5.21M-98.64%
Mar 31, 2023
5.28M-10.13M-65.73%
Mar 31, 2022
15.41M12.90M+515.34%
Mar 31, 2021
2.50M-8.80M-77.84%
Mar 31, 2020
11.30M-144.51M-92.75%
Mar 31, 2019
155.81M-198.60M-56.04%
Mar 31, 2018
354.41M